Govt approves vaccination for 15-18 age grp; booster shots for 60+, frontline workers: PM
New Delhi/IBNS: Prime Minister Narendra Modi today announced that the government has approved vaccination shots for children aged 15 and 18 years and the vaccination drive will start from January 3 (Monday).
More relief for Indian travellers, UK will now recognise Covaxin from Nov 22
London/New Delhi/UNI: In more relief for Indian travellers, Britain said on Monday that from November 22 it will recognise Covid-19 vaccines on the WHO’s Emergency Use Listing, including Bharat Biotech’s Covaxin.
Australia recognises Bharat Biotech's Covaxin for travel purposes
Canberra/New Delhi/IBNS: Easing curbs on international travel, Australia has recognised Indian biotechnology company Bharat Biotech's anti-COVID-19 vaccine, Covaxin, for travel purposes.
Mansukh Mandaviya releases first commercial batch of COVAXIN manufactured in Ankleshwar
New Delhi: Union Minister for Health and Family Welfare and Chemical and Fertilizer Mansukh Mandaviya on Sunday released the first commercial batch of COVAXIN from Chiron Behring Vaccines facility of Bharat Biotech in Ankleshwar, Gujarat.
Three arrested while smuggling Covid vaccines, medicines to Myanmar
Imphal/IBNS: Three persons have been arrested for allegedly trying to smuggle Covid vaccines and other medicines to Myanmar, Manipur Police said.
Bharat Biotech ends Covaxin supply agreements with Brazilian firms amid political row
Hyderabad/IBNS: Drug manufacturer Bharat Biotech on Friday informed that it has cancelled agreements with two Brazilian companies amid controversy over a $324 million deal with the South American country for the import of 20 million doses of the made-in-India COVID-19 vaccine-Covaxin.
Accept Covishield, Covaxin or face consequences: India to European Union
New Delhi/IBNS: In a strong-worded communication, India has asked the European Union that either Covishield and Covaxin must be notified in its digital COVID certificate or people from the EU will face mandatory quarantine upon arrival in the Asian country.
Brazil suspends $324 million contract to buy Bharat Biotech's Covaxin doses
New Delhi/IBNS: Brazil has announced the suspension of the $324 million contract to buy 20 million doses of Bharat Biotech's anti-COVID-19 vaccine, Covaxin, media reports said.
Problem of Indian students who received Covaxin raised with US
New Delhi/IBNS: India has raised the concerns of students vaccinated with indigenously developed Covaxin and planning a return to US educational institutions during a meeting between foreign secretary Harsh Shringla and US chargé d’ affaires Daniel Smith, said a Hindustan Times report.
Punjab revokes order of selling COVID-19 vaccines to pvt hospitals facing scam charge
Chandigarh/IBNS: After getting caught in the midst of a controversy, the Congress government in Punjab has revoked its own decision of selling COVID-19 vaccines to private hospitals at a higher price, media reports said.
No mixing of vaccines, or single dose of Covishield yet: Centre
New Delhi/IBNS: The Centre on Tuesday rejected claims that it could allow mixing of vaccines and reduce the Covishield vaccine schedule to a single shot, after unofficial sources informed media about the key pointers of such a plan, eliciting resistance from the medical community.
No consensus on vaccine passport yet at WHO level: Centre
New Delhi/IBNS: The World Health Organization (WHO) is yet to reach a consensus on vaccine passport, which will enable international travel for individuals who have received coronavirus vaccine jabs, Health Ministry joint secretary Lav Agarwal said Saturday, media reports said.
Covaxin neutralizes coronavirus variants found in India, UK
Hyderabad/IBNS: Bharat Biotech has announced that Covid-19 vaccine - COVAXIN, produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first found in India and the United Kingdom.
Pvt institutions can come forward for Covid19 vaccine production: Centre
New Delhi/IBNS: Private firms can come forward to scale up India's vaccine production and the matter is being considered, Niti Aayog (health) member Dr VK Paul said on Saturday, adding that such decisions involving transfer of technology and knowledge entail a long process.
Sisodia says Bharat Biotech refused to supply vaccine doses demanded by Delhi, hits out at Centre
Delhi/IBNS: Delhi Deputy Chief MinisterManish Sisodia has hit out at the Centre's vaccine management saying that Covaxin manufacturer BharatBiotech has refused to supply the vaccine to the national capital.